The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...

New antibiotic has been approved for uncomplicated UTIs; Cabometyx approved for advanced neuroendocrine tumors; new rosacea treatment option; Tremfya ...

The Food and Drug Administration (FDA) has approved Vykat™ XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome ...

HealthDay News — Avoidable mortality is increasing in the US and decreasing in comparator countries, according to a study published online March 24 in JAMA Internal Medicine.

Withdrawing renin-angiotensin inhibitors/angiotensin receptor-neprilysin inhibitors and mineralocorticoid receptor antagonists tied to higher one-year mortality, morbidity.

Even without these two expanding clusters, the total number of cases in the U.S. has exceeded the case count for the entire year of 2024 ...

HealthDay News — Preliminary data released this month by the US Centers for Disease Control and Prevention indicate that more than 10,300 tuberculosis (TB) cases were reported last year, representing ...

In a recent study, significantly more patients receiving the combination therapy met primary end point of reduction in spleen volume.

The F8 formulation is 8 times more concentrated than Egrifta and 2 times more concentrated than the current F4 formulation, Egrifta SV.

Topline results were announced from a phase 3 trial evaluating simufilam, an oral small molecule that targets the filamin A protein, for the treatment of mild to moderate Alzheimer disease (AD).

HealthDay News — The federal government is clawing back $11.4 billion in COVID funding, a move that could affect local and state public health efforts across the country. The US Department of Health ...

Vaccine series completion for rotavirus, DTaP, PCV at 12 months was highest in January 2020 and remained lower in October 2023.